scispace - formally typeset
Open AccessJournal ArticleDOI

L- and T-type calcium channels control aldosterone production from human adrenals

Reads0
Chats0
TLDR
It is concluded that T- and L-type calcium channels play equally important roles in controlling aldosterone production from human adrenals.
Abstract
Aldosterone, which plays a key role in the regulation of blood pressure, is produced by zona glomerulosa (ZG) cells of the adrenal cortex. Exaggerated overproduction of aldosterone from ZG cells causes primary hyperaldosteronism. In ZG cells, calcium entry through voltage-gated calcium channels plays a central role in the regulation of aldosterone secretion. Previous studies in animal adrenals and human adrenal adrenocortical cell lines suggest that the T-type but not the L-type calcium channel activity drives aldosterone production. However, recent clinical studies show that somatic mutations in L-type calcium channels are the second most prevalent cause of aldosterone-producing adenoma. Our objective was to define the roles of T and L-type calcium channels in regulating aldosterone secretion from human adrenals. We find that human adrenal ZG cells mainly express T-type CaV3.2/3.3 and L-type CaV1.2/1.3 calcium channels. TTA-P2, a specific inhibitor of T-type calcium channel subtypes, reduced basal aldosterone secretion from acutely prepared slices of human adrenals. Surprisingly, nifedipine, the prototypic inhibitor of L-type calcium channels, also decreased basal aldosterone secretion, suggesting that L-type calcium channels are active under basal conditions. In addition, TTA-P2 or nifedipine also inhibited aldosterone secretion stimulated by angiotensin II- or elevations in extracellular K+. Remarkably, blockade of either L- or T-type calcium channels inhibits basal and stimulated aldosterone production to a similar extent. Low concentrations of TTA-P2 and nifedipine showed additive inhibitory effect on aldosterone secretion. We conclude that T- and L-type calcium channels play equally important roles in controlling aldosterone production from human adrenals.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders

TL;DR: The literature on L‐VDCC expression and function in the CNS and on microglia in vitro and in vivo is reviewed and the therapeutic landscape of L-VDCC‐targeting agents at present and future challenges in the context of Alzheimer's disease, Parkinson’s disease, Huntington's Disease, neuropsychiatric diseases, and other CNS disorders are explored.
Journal ArticleDOI

Cellular Pathophysiology of Mutant Voltage-Dependent Ca2+ Channel CACNA1H in Primary Aldosteronism.

TL;DR: The pathogenesis of stimulus-independent aldosterone production in patients with CACNA1H mutations involves several factors: a loss of normal control of the membrane potential, an increased Ca2+ influx at basal conditions, and alterations in sensitivity to extracellular K+ and Na+.
Journal ArticleDOI

The role of lipid second messengers in aldosterone synthesis and secretion

TL;DR: In this article , the authors examine the mechanisms by which these lipid second messengers modulate aldosterone production at multiple levels. But, they also highlight the gaps in their knowledge, such as the preference for phospholipase D-generated PA or DAG, as well as the need for further investigation to elucidate the precise mechanism by which those lipid secondmessengers regulate optimal aldosteronism.
Journal ArticleDOI

Cav1.3‐selective inhibitors of voltage‐gated L‐type Ca2+ channels: Fact or (still) fiction?

TL;DR: In this article , the authors conclude that at present no pharmacological tools exist that are suitable to confirm or refute a role of Cav1.3 channels in cellular responses in preclinical models.
References
More filters
Journal ArticleDOI

Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels

TL;DR: The goal of this review is to provide a comprehensive description of T-type currents, their distribution, regulation, pharmacology, and cloning.
Journal ArticleDOI

Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism : An Endocrine Society Clinical Practice Guideline

TL;DR: The Task Force developed clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism and recommended that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Journal ArticleDOI

A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

TL;DR: This work demonstrates complete linkage of GRA in a large kindred to a gene duplication arising from unequal crossing over, fusing the 5' regulatory region of 11β-hydroxylase to the coding sequences of aldosterone synthase.
Journal ArticleDOI

Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension

TL;DR: The data provide strong evidence that hyperaldosteronism is a common cause of resistant hypertension in black and white subjects and the accuracy of these results is strengthened by having done suppression testing of all evaluated subjects.
Related Papers (5)